Conference call and webcast at 8:30 a.m. Eastern Time today NEW YORK, March 31, 2025 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today announced financial results for the fiscal year ended December 31, 2024, and provided a corporate update. Fourth Quarter 2024 and Recent Highlights December 30, 2024: Issued a letter to shareholders summarizing key corporate achievements and strategic priorities for 2025 ...